ES504513A0 - Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario. - Google Patents

Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.

Info

Publication number
ES504513A0
ES504513A0 ES504513A ES504513A ES504513A0 ES 504513 A0 ES504513 A0 ES 504513A0 ES 504513 A ES504513 A ES 504513A ES 504513 A ES504513 A ES 504513A ES 504513 A0 ES504513 A0 ES 504513A0
Authority
ES
Spain
Prior art keywords
solubilization
stabilization
procedure
antiparasitic agent
antiparasitic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES504513A
Other languages
English (en)
Other versions
ES8607721A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES504513A0 publication Critical patent/ES504513A0/es
Publication of ES8607721A1 publication Critical patent/ES8607721A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES504513A 1980-08-04 1981-08-03 Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario. Expired ES8607721A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17495780A 1980-08-04 1980-08-04

Publications (2)

Publication Number Publication Date
ES504513A0 true ES504513A0 (es) 1986-06-01
ES8607721A1 ES8607721A1 (es) 1986-06-01

Family

ID=22638223

Family Applications (1)

Application Number Title Priority Date Filing Date
ES504513A Expired ES8607721A1 (es) 1980-08-04 1981-08-03 Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.

Country Status (17)

Country Link
EP (1) EP0045655B1 (es)
JP (1) JPS5765330A (es)
KR (1) KR860001503B1 (es)
AR (1) AR229354A1 (es)
AT (1) ATE12179T1 (es)
AU (1) AU551280B2 (es)
CA (1) CA1162857A (es)
DE (1) DE3169381D1 (es)
DK (1) DK163637C (es)
ES (1) ES8607721A1 (es)
GR (1) GR74604B (es)
IE (1) IE51460B1 (es)
NZ (1) NZ197796A (es)
OA (1) OA06863A (es)
PT (1) PT73471B (es)
YU (1) YU183181A (es)
ZA (1) ZA815317B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485099A (en) * 1983-06-15 1984-11-27 Merck & Co., Inc. Renin inhibitors containing a C-terminal amide cycle
US4477440A (en) * 1983-09-14 1984-10-16 Merck & Co., Inc. Renin inhibitors containing an n-terminal disulfide cycle
NZ210505A (en) * 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
ZA89552B (en) * 1988-01-29 1989-10-25 Merrell Dow Pharma Pharmaceutical composition for 4-aroylimidazol-2-ones
GB8803836D0 (en) * 1988-02-18 1988-03-16 Glaxo Group Ltd Compositions
JP2680614B2 (ja) * 1988-08-01 1997-11-19 日清製粉株式会社 ダナゾール組成物
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
US5602107A (en) * 1993-05-10 1997-02-11 Merck & Co., Inc. Pour-on formulations consisting of gylcols, glycerides and avermectin compounds
RO115102B1 (ro) * 1993-05-10 1999-11-30 Merck & Co Inc Formulari topice pe baza de avermectina si procedee de preparare a acestora
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
JP2855181B2 (ja) 1993-12-10 1999-02-10 敏雄 鈴木 松類の枯損防止用組成物及び防止方法
DE19613972A1 (de) * 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
MXPA01007486A (es) * 1999-01-25 2003-06-24 Optime Therapeutics Inc Formulaciones de liposomas.
US6780885B1 (en) * 2000-01-14 2004-08-24 Idexx Laboratories, Inc. Formulations and methods for administration of pharmacologically or biologically active compounds
RU2162699C1 (ru) * 2000-02-14 2001-02-10 Закрытое Акционерное Общество "Нита-Фарм" Водно-дисперсная лекарственная форма ивермектина для лечения экто- и эндопаразитозов
BG64140B1 (bg) * 2000-12-21 2004-02-27 "Биовет" Ад Състав за растителна защита с инсектицидно и акарицидно действие
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
DE10331253B4 (de) * 2003-01-28 2007-03-08 Alpha-Biocare Gmbh Therapeutika gegen Parasiten von Fischen
FR2854074B1 (fr) 2003-04-24 2007-11-23 Galderma Res & Dev Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
GB0316377D0 (en) 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US20080125480A1 (en) * 2004-12-30 2008-05-29 Cheminova A/S Oil-In-Water Formulation Of Avermectins
FR2894823B1 (fr) 2005-12-20 2008-02-29 Galderma Sa Composition de type emulsion inverse comprenant de l'ivermectine, et ses utilisations en cosmetique et en dermatologie
MX2011003720A (es) 2008-10-08 2011-04-28 Wyeth Llc Composiciones antihelminticas de bencimidazol.
BRPI0804639A2 (pt) * 2008-10-23 2010-07-20 Formil Veterinaria Ltda processo para preparação de formulação de suspensão veterinária para administração de medicamento insolúvel em água, por meio de sistemas de distribuição de água e respectiva formulação de suspensão veterinária para administração de medicamento insolúvel em água
CA2741886C (en) 2008-10-29 2018-05-01 Topaz Pharmaceuticals Inc. Preservative system for emulsion-based therapeutic topical formulations
JP5717034B2 (ja) * 2012-08-27 2015-05-13 丸和バイオケミカル株式会社 マクロライド系化合物を含有する土壌線虫防除用薬剤
CN104884508A (zh) 2013-03-06 2015-09-02 积水化学工业株式会社 树脂复合材料的制造方法及树脂复合材料
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
FR3042412A1 (fr) * 2015-10-14 2017-04-21 Biotopic Pharmaceuticals Formulation pharmaceutique stabilisee et prete a l'emploi d'ivermectine dans le traitement des parasitoses humaines et animales
CN107802599A (zh) * 2017-12-08 2018-03-16 宁夏大学 一种驼用饮水型驱虫溶液的研制和使用方法
PT110634B (pt) 2018-03-19 2021-03-17 Hovione Farmaciencia Sa Ivermectina amorfa e processo para a sua produção
CN109966438A (zh) * 2019-05-17 2019-07-05 石家庄九鼎动物药业有限公司 一种兽用抗寄生虫药物伊维菌素注射液及其制备方法
US11638714B2 (en) 2020-11-10 2023-05-02 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes
US11077134B1 (en) 2020-11-10 2021-08-03 Mountain Valley Md Inc Water dissolvable macrocyclic lactone cyclodextrin complexes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB784659A (en) * 1954-11-26 1957-10-16 Upjohn Co Therapeutic compositions and aqueous suspensions thereof
CH420490A (de) * 1961-10-16 1966-09-15 Hoffmann La Roche Wässriges Verdünnungsmittel zur Herstellung von parenteralen Injektionslösungen und Verfahren zu dessen Herstellung
GB1225979A (es) * 1967-03-23 1971-03-24
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof

Also Published As

Publication number Publication date
IE51460B1 (en) 1986-12-24
NZ197796A (en) 1984-11-09
DE3169381D1 (en) 1985-04-25
DK345081A (da) 1982-02-05
PT73471B (en) 1983-07-06
IE811751L (en) 1982-02-04
ES8607721A1 (es) 1986-06-01
OA06863A (fr) 1983-02-28
CA1162857A (en) 1984-02-28
EP0045655A3 (en) 1982-10-06
JPS5765330A (en) 1982-04-20
ZA815317B (en) 1983-03-30
EP0045655A2 (en) 1982-02-10
YU183181A (en) 1984-02-29
DK163637B (da) 1992-03-23
DK163637C (da) 1992-08-17
EP0045655B1 (en) 1985-03-20
AR229354A1 (es) 1983-07-29
AU551280B2 (en) 1986-04-24
GR74604B (es) 1984-06-29
KR860001503B1 (ko) 1986-09-30
JPH057371B2 (es) 1993-01-28
ATE12179T1 (de) 1985-04-15
KR830005849A (ko) 1983-09-14
PT73471A (en) 1981-09-01
AU7361281A (en) 1982-02-11

Similar Documents

Publication Publication Date Title
ES504513A0 (es) Un procedimiento para la solubilizacion y estabilizacion de un agente antiparasitario.
ES528628A0 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES504291A0 (es) Un procedimiento para la preparacion de benzotio-en y benzofuransulfonamidas.
IT8224141A0 (it) Procedimento ed apparecchiatura per formare film mediante gonfiaggio.
IT7924910A0 (it) Procedimento per la fabbricazione di un proietto decalibrato e proietto decalibrato realizzato con tale procedimento.
ES510326A0 (es) Procedimiento para la obtencion de un agente que evita la caida del cabello y fomenta su crecimiento a base de fosfatidos.
IT8321018A0 (it) Agente immunomodulante.
ES493941A0 (es) Un procedimiento para encapsular un agente anti-suciedad.
IT8420889A0 (it) Agente anti-russamento.
ES514540A0 (es) "procedimiento para la recuperacion de un aceite exhausto".
NO158850C (no) Respirator.
ES511630A0 (es) "procedimiento para la descomposicion de eteres alquil ter-alquilicos".
ES515513A0 (es) Procedimiento y dispositivo para la fabricacion de un dulce hueco.
ES513972A0 (es) "procedimiento para la estabilizacion de compuestos fotocromicos".
MX5719A (es) N-fenilsulfonil-n'-pirimidinil y -triazinil-ureas y procedimiento para su preparacion.
ES499105A0 (es) Procedimiento para la fabricacion de un cuerpo metalico hue-co con paredes macizas.
ES546059A0 (es) Un procedimiento para la fabricacion de un dispositivo osmatico para la descarga controlada de un agente util.
ZA814217B (en) Process and agent, and also their use, for the stabilization of alkaline phosphatase
IT8125501A0 (it) Procedimento ed apparecchiatura di confezionamento.
ES514220A0 (es) "procedimiento para la fabricacion de (tienil-2)-2 etilaminas y (tienil-3)-2 etilaminas".
CS191336B2 (en) Insecticide,acricide and nematocide means and method of making the active substances
IT8219647A0 (it) Agente cardiostimolante oppure cardiotonico.
ES524059A0 (es) Procedimiento para la preparacion de un agente para el tratamiento de heridas
ES510494A0 (es) "procedimiento para la obtencion de un agente antihelmintico".
ES512018A0 (es) Procedimiento y dispositivo para la alimentacion de un generador de gas.